This study aimed to evaluate the efficacy and safety of a comprehensive, multi-target injection protocol, termed 'PRP Spinoplasty,' for managing chronic LBP stemming from concurrent lumbar disc and facet joint disease with associated muscle spasms.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Individuals of both sexes; ages between 18 and 80 years.
* Lower back pain consistent with lumbosacral radiculopathy, facet arthropathy, and muscle spasms.
* MRI-confirmed lumbar spine pathology (disc disease and/or facet arthropathy).
* Failure to respond to at least 3 months of conservative therapy (NSAIDS and physical therapy).
* Pain score ≥ 6; on the 10-point Numeric Pain Scale (NPS) at baseline.
Exclusion Criteria:
* Presence of local or systemic infection, or fever.
* Diagnosed with cancer within the past 12 months.
* Unable to give a consent.
* History of spinal deformity such as fracture, or severe spinal stenosis causing neurological deficit.
* Presence of lower extremity weakness or urinary tract symptoms related to spinal pathology.
* Previous spinal decompression or fusion surgery at the treatment level.
* Receipt of any spine injection within the previous 12 months.
* Use of NSAIDs within 2 weeks prior to, or 6 weeks following the procedure.
* Use of corticosteroids within 6 weeks prior, or after the procedure.
* Use of anticoagulation or antiplatelet drugs (excluding low-dose Aspirin).
* History of blood disorders.
* History of any major surgery within the past 3 months.
What they're measuring
1
Quantifying pain intensity using Numeric Pain Scale (NPS)
Timeframe: 0-6 months
2
Assessing level of functional disability using Oswestry Disability Index (ODI)
Timeframe: 0-6 months
3
Assessing patient's condition using Single Assessment Numeric Evaluation (SANE)